Not really. That 5.5 million or so will be burnt through very quickly with a multi-country trial and possibly looking to commence a separate trial in the US. Spend was at roughly 2m in the previous quarter and it won't be lower than that going forward. 2-3 quarters left. Im sure they'll start dangling the 'partnerships' carrot soon like every other Aussie biotech, and it'll likely amount to nothing like every other biotech! Some mid-way efficacy and a raise at slightly higher prices I assume is what they're trying to hang on for.. Unsure if that'll be feasible.
- Forums
- ASX - By Stock
- ATX
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
|
|||||
Last
8.8¢ |
Change
0.002(2.33%) |
Mkt cap ! $24.13M |
Open | High | Low | Value | Volume |
8.6¢ | 9.2¢ | 8.5¢ | $53.15K | 599.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 44983 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 7898 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 55117 | 0.088 |
1 | 100000 | 0.086 |
4 | 277434 | 0.085 |
2 | 130000 | 0.083 |
6 | 420000 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 7898 | 1 |
0.099 | 11000 | 1 |
0.100 | 55000 | 1 |
0.110 | 25000 | 1 |
0.115 | 228398 | 2 |
Last trade - 14.49pm 31/07/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online